M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Atossa Therapeutics secures new US patent for (Z)-endoxifen formulations
Clinical-stage biopharmaceutical company Atossa Therapeutics Inc (Nasdaq:ATOS) announced on Tuesday that it has been granted US Patent No. 12,275,684, expanding its intellectual property portfolio for (Z)-endoxifen, a Selective Estrogen Receptor Modulator.
The patent covers enteric oral...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search